Khera Angela J, Chase Janet W, Salzberg Michael, Thompson Alexander J V, Kamm Michael A
Department of Gastroenterology, St Vincent's Hospital, Melbourne and University of Melbourne, Melbourne, Australia.
Inflamm Bowel Dis. 2019 Feb 21;25(3):620-626. doi: 10.1093/ibd/izy344.
Patients with inflammatory bowel disease (IBD) often experience functional bowel symptoms despite achieving disease remission. Although behavioral treatment (bowel and pelvic floor muscle retraining) is effective for managing constipation or fecal incontinence in non-IBD patients, there is limited evidence for its efficacy in patients with quiescent inflammatory bowel disease. The aim of this study was to evaluate the outcome of gut-directed behavioral treatment, including pelvic floor muscle training, for symptoms of constipation or fecal incontinence in patients with IBD in disease remission.
The outcome of consecutive patients with IBD in remission and symptoms of constipation or fecal incontinence was evaluated. Patients referred to a multidisciplinary gastroenterology clinic underwent gut-directed behavioral treatment, including pelvic floor muscle training. The primary outcome was patient-reported rating of change in symptoms on a 7-point Likert scale at the completion of treatment.
Forty IBD patients (median age, 35 years; 80% female; 24 Crohn's disease [CD], 12 ulcerative colitis [UC], 4 UC with ileoanal pouch) with ongoing symptoms of constipation (55%) or fecal incontinence (45%), despite drug therapy, were included. The median symptom duration at referral was 2 years. Thirty-five (87%) completed treatment with a median of 2 sessions. Improvement of "6 = much better" or "7 = very much better" was reported by 77% (17/22) with fecal incontinence and 83% (15/18) with constipation. Improvement occurred irrespective of IBD diagnosis, previous perianal fistulae, colorectal surgery, presence of an ileoanal pouch, or past obstetric trauma.
Behavioral treatment effectively improves functional gut symptoms in a large majority of patients who are in IBD disease remission and who have not responded to drug therapy. 10.1093/ibd/izy344_video1 izy344.video1 5968879349001.
炎症性肠病(IBD)患者即便疾病已缓解,仍常出现肠道功能症状。尽管行为治疗(肠道及盆底肌肉再训练)对非IBD患者的便秘或大便失禁有效,但在静止期炎症性肠病患者中,其疗效证据有限。本研究旨在评估肠道定向行为治疗(包括盆底肌肉训练)对处于疾病缓解期的IBD患者便秘或大便失禁症状的治疗效果。
对连续的处于缓解期且有便秘或大便失禁症状的IBD患者的治疗效果进行评估。转诊至多学科胃肠病诊所的患者接受了肠道定向行为治疗,包括盆底肌肉训练。主要结局指标是患者在治疗结束时报告的症状变化的7分李克特量表评分。
纳入了40例IBD患者(中位年龄35岁;80%为女性;24例克罗恩病[CD],12例溃疡性结肠炎[UC],4例回肠肛管袋状吻合术的UC),尽管接受了药物治疗,但仍持续存在便秘症状(55%)或大便失禁症状(45%)。转诊时症状的中位持续时间为2年。35例(87%)完成了治疗,中位治疗次数为2次。大便失禁患者中有77%(17/22)报告症状改善为“6 =好多了”或“7 =非常好多了”,便秘患者中有83%(15/18)报告症状改善。无论IBD诊断、既往肛周瘘管、结直肠手术、回肠肛管袋的存在或既往产科创伤情况如何,均出现了症状改善。
行为治疗能有效改善大多数处于IBD疾病缓解期且对药物治疗无反应的患者的肠道功能症状。10.1093/ibd/izy344_video1 izy344.video1 5968879349001